RXST
RxSight, Inc.
Key Financials
Operating Income
$-48191000
↓ 30.7%
Revenue
$64.6M
N/A
Gross Profit
$103.0M
↑ 4.1%
Net Income
$-38944000
↓ 41.8%
Total Assets
$311.8M
↓ 2.1%
EPS (Diluted)
$-0.95
↓ 33.8%
Total Liabilities
$36.1M
↓ 3.2%
Cash & Equivalents
$19.9M
↑ 19.4%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| SC TO-I | 8/10/2026 | View on SEC |
| 10-Q | 8/5/2026 | View on SEC |
| 8-K | 8/5/2026 | View on SEC |
| SCHEDULE 13G/A | 8/4/2026 | View on SEC |
| 4 | 7/24/2026 | View on SEC |
| 3 | 7/24/2026 | View on SEC |
| S-8 | 7/23/2026 | View on SEC |
| SCHEDULE 13G | 7/17/2026 | View on SEC |
| 8-K | 7/15/2026 | View on SEC |
| 8-K | 7/6/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | RXST |
| Company Name | RxSight, Inc. |
| CIK | 1111485 |
| Sector | Ophthalmic Goods |
| Industry | Accelerated filer |
| Exchange | Nasdaq |
| SIC Code | 3851 |
| SIC Description | Ophthalmic Goods |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | 949-521-7822 |